Have you or your loved ones been diagnosed with advanced solid tumors cancer?

You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors cancer? You may be eligible to participate in a advanced solid tumors cancer clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Solid Tumors Cancer Clinical Trial
NCT02955251 | Phase 1 | Interventional
AbbVie
Sponsored by
AbbVie

Have you or your loved ones been diagnosed with advanced solid tumors cancer?

You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors cancer? You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Completed

Male & Female

18 - 99

Years old

This study has recruited 61 Participants

This is an open-label, Phase I, dose-escalation study to determine the recommended Phase 2 dose (RPTD), maximum tolerated dose (MTD), and evaluate the safety and pharmacokinetic (PK) profile of ABBV-428 when administered as monotherapy or in combination with nivolumab in participants with advanced solid tumors.